Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).

ICCR biopsy checklist dataset guidelines resection soft-tissue sarcoma synoptic report

Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Apr 2023
Historique:
revised: 22 12 2022
received: 06 10 2022
accepted: 23 12 2022
pubmed: 12 1 2023
medline: 4 3 2023
entrez: 11 1 2023
Statut: ppublish

Résumé

Soft-tissue tumours are rare and both accurate diagnosis and proper treatment represent a global challenge. Current treatment guidelines also recommend review by specialised pathologists. Here we report on international consensus-based datasets for the pathology reporting of biopsy and resection specimens of soft-tissue sarcomas. The datasets were produced under the auspices of the International Collaboration on Cancer Reporting (ICCR), a global alliance of international pathology and cancer organisations. According to the ICCR's guidelines for dataset development, an international expert panel consisting of pathologists, a surgical oncologist, and a medical oncologist produced a set of core and noncore data items for biopsy and resection specimens based on a critical review and discussion of current evidence. All professionals involved were subspecialised soft-tissue sarcoma experts and affiliated with tertiary referral centres. Commentary was provided for each data item to explain the rationale for selecting it as a core or noncore element, its clinical relevance, and to highlight potential areas of disagreement or lack of evidence, in which case a consensus position was formulated. Following international public consultation, the documents were finalised and ratified, and the datasets, which included a synoptic reporting guide, were published on the ICCR website. These first international datasets for soft-tissue sarcomas are aimed to promote high-quality, standardised pathology reporting. Their adoption will improve consistency of reporting, facilitate multidisciplinary communication, and enhance comparability of data, all of which will help to improve patient's management.

Identifiants

pubmed: 36631406
doi: 10.1111/his.14862
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

745-754

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Thway K, Fisher C. Histopathological diagnostic discrepancies in soft-tissue tumours referred to a specialist centre. Sarcoma 2009; 2009; 741975.
Ray-Coquard I, Montesco MC, Coindre JM et al. Sarcoma: concordance between initial diagnosis and centralised expert review in a population-based study within three European regions. Ann. Oncol. 2012; 23; 2442-2449.
Rupani A, Hallin M, Jones RL, Fisher C, Thway K. Diagnostic differences in expert second-opinion consultation cases at a tertiary sarcoma center. Sarcoma. 2020; 29; 9810170.
Haas R, Hassan AB, Hecker-Nolting S et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol 2021; 32; 1348-1365.
Recommendations for the reporting of soft-tissue sarcomas. Association of Directors of Anatomic And Surgical Pathology. Mod. Pathol. 1998; 11; 1257-1261.
Royal College of Pathologists. Dataset for histopathological reporting of soft-tissue sarcoma. 2017. Available at: https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
College of American Pathologists. Protocol for the Examination of Biopsy Specimens From Patients With Soft Tissue Tumors. 2021. Available at: https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates
College of American Pathologists. Protocol for the Examination of Resection Specimens From Patients With Soft Tissue Tumors. 2021. Available at: https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates
International Collaboration on Cancer Reporting. Soft Tissue Sarcoma Histopathology Reporting Guide - Biopsy Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
International Collaboration on Cancer Reporting. Soft Tissue Sarcoma Histopathology Reporting Guide - Resection Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
Merlin T, Weston A, Tooher R. Extending an evidence hierarchy to include topics other than treatment: revising the Australian ‘levels of evidence’. BMC Med. Res. Methodol. 2009; 9; 34.
International Collaboration on Cancer Reporting. Primary Tumour in Bone Histopathology Reporting Guide - Biopsy Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
International Collaboration on Cancer Reporting. Primary Tumour in Bone Histopathology Reporting Guide - Resection Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
International Collaboration on Cancer Reporting. Gastrointestinal Stromal Tumour (GIST) Histopathology Reporting Guide - Biopsy Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
International Collaboration on Cancer Reporting. Gastrointestinal Stromal Tumour (GIST) Histopathology Reporting Guide - Resection Specimens. 1st edition. 2021. Available at: http://www.iccr-cancer.org/datasets/published-datasets/soft-tissue-bone
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. WHO classification of tumours, 5th edition, volume 3. Lyon: IARC Publications, 2020.
Fritz A, Percy C, Jack A et al. International classification of diseases for oncology. Geneva: World Health Organization, 2000.
Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft-tissue sarcoma. J. Clin. Oncol. 1997; 15; 350-362.
Gronchi A, Palmerini E, Quagliuolo V et al. Neoadjuvant chemotherapy in high-risk soft-tissue sarcomas: final results of a randomised trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. J. Clin. Oncol. 2020; 38; 2178-2186.
Wardelmann E, Haas RL, Bovée JV et al. Evaluation of response after neoadjuvant treatment in soft-tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. Eur. J. Cancer 2016; 53; 84-95.
Gustafson P, Akerman M, Alvegård TA et al. Prognostic information in soft-tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system. Eur. J. Cancer 2003; 39; 1568-1576.
Engellau J, Bendahl PO, Persson A et al. Improved prognostication in soft-tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum. Pathol. 2005; 36; 994-1002.
Brierley JD, Gospodarowicz MK, Wittekind C eds. Union for International Cancer Control. TNM classification of malignant tumours. 8th ed. USA: Wiley, 2016.
Amin M, Edge S, Greene F et al. AJCC cancer staging manual. 8th ed. New York: Springer, 2017.
Baranov NS, Nagtegaal ID, van Grieken NCT et al. Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports. Virchows Arch. 2019; 475; 255-259.
Sluijter CE, van Workum F, Wiggers T et al. Improvement of Care in Patients with Colorectal Cancer: Influence of the introduction of standardised structured reporting for pathology. JCO Clin. Cancer Inform. 2019; 3; 1-12.
Gill AJ, Johns AL, Eckstein R et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 2009; 41; 161-167.

Auteurs

Angelo Paolo Dei Tos (AP)

Department of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.
Department of Medicine, University of Padua School of Medicine, Padua, Italy.

Fleur Webster (F)

International Collaboration on Cancer Reporting, Sydney, NSW, Australia.

Abbas Agaimy (A)

Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.

Judith Bovée (J)

Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.

Brendan Dickson (B)

Department of Pathology & Laboratory Medicine, Mount Sinai Hospital and Department of Pathobiology & Laboratory Medicine, University of Toronto, Toronto, ON, Canada.

Leona Doyle (L)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sarah Dry (S)

Department of Pathology, University of California, Los Angeles, CA, USA.

Alessandro Gronchi (A)

Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Meera Hameed (M)

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Chris Hemmings (C)

Department of Anatomic Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.
Department of Pathology and Biomedical Science, University of Otago Medical School, Christchurch, New Zealand.

Bernadette Liegl-Atzwanger (B)

Diagnostic and Research Institute of Pathology, Comprehensive Cancer Centre Graz, Medical University of Graz, Graz, Austria.

Khin Thway (K)

The Royal Marsden NHS Foundation Trust, London, UK.
The Institute of Cancer Research, London, UK.

Andrew J Wagner (AJ)

Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Jian Wang (J)

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Akihiko Yoshida (A)

Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.

Christopher Fletcher (C)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH